Gene: DPPA2
Official Full Name: developmental pluripotency associated 2provided by HGNC
Gene Summary: Predicted to enable chromatin binding activity. Predicted to be involved in system development. Predicted to act upstream of or within several processes, including epigenetic regulation of gene expression; lung-associated mesenchyme development; and positive regulation of stem cell proliferation. Located in nucleoplasm. [provided by Alliance of Genome Resources, Jul 2025]
| Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
|---|---|---|---|---|---|---|
| KOA04482 | DPPA2 Knockout cell line (AC16) | Human | DPPA2 | 1:3-1:4 | negative | Online Inquiry |
| KOA19927 | DPPA2 Knockout cell line (BEAS-2B) | Human | DPPA2 | 1:3~1:4 | negative | Online Inquiry |
| KOA35374 | DPPA2 Knockout cell line (U-2932) | Human | DPPA2 | 1:2-1:4 | negative | Online Inquiry |
| KOA50782 | DPPA2 Knockout cell line (TPC-1) | Human | DPPA2 | 1:5-1:8 | negative | Online Inquiry |
| KOA66187 | DPPA2 Knockout cell line (NCM460) | Human | DPPA2 | 1:2~1:3 | negative | Online Inquiry |
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.